KEY TRONIC CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that KEY TRONIC CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 28, 2025 | $467.87M | Sep 17, 2025 |
| FY2024 | Jun 29, 2024 | $126.56M | Oct 15, 2024 |
| FY2024 | Mar 30, 2024 | $142.43M | Oct 15, 2024 |
| FY2024 | Dec 30, 2023 | $147.85M | Oct 15, 2024 |
| FY2024 | Sep 30, 2023 | $150.11M | Oct 15, 2024 |
| FY2024 | Jul 1, 2023 | $168.99M | Oct 15, 2024 |
| FY2024 | Apr 1, 2023 | $167.76M | Oct 15, 2024 |
| FY2024 | Dec 31, 2022 | $127.59M | Oct 15, 2024 |
| FY2024 | Oct 1, 2022 | $140.97M | Oct 15, 2024 |
| FY2024 | Jul 2, 2022 | $133.93M | Oct 15, 2024 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Jun 30, 2018 | $117.03M | Sep 10, 2018 |
| FY2018 | Mar 31, 2018 | $108.35M | Sep 10, 2018 |
| FY2018 | Dec 30, 2017 | $111.73M | Sep 10, 2018 |
| FY2018 | Sep 30, 2017 | $109.22M | Sep 10, 2018 |
| FY2018 | Jul 1, 2017 | $118.54M | Sep 10, 2018 |
| FY2018 | Apr 1, 2017 | $113.60M | Sep 10, 2018 |
| FY2018 | Dec 31, 2016 | $118.52M | Sep 10, 2018 |
| FY2018 | Oct 1, 2016 | $117.14M | Sep 10, 2018 |
| FY2017 | Jul 2, 2016 | $123.91M | Sep 11, 2017 |
| FY2017 | Apr 2, 2016 | $118.45M | Sep 11, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 28, 2025 | $36.43M | Sep 17, 2025 |
| FY2024 | Jun 29, 2024 | $9.17M | Oct 15, 2024 |
| FY2024 | Mar 30, 2024 | $8.08M | Oct 15, 2024 |
| FY2024 | Dec 30, 2023 | $11.76M | Oct 15, 2024 |
| FY2024 | Sep 30, 2023 | $10.86M | Oct 15, 2024 |
| FY2024 | Jul 1, 2023 | $13.90M | Oct 15, 2024 |
| FY2024 | Apr 1, 2023 | $14.28M | Oct 15, 2024 |
| FY2024 | Dec 31, 2022 | $8.92M | Oct 15, 2024 |
| FY2024 | Oct 1, 2022 | $10.38M | Oct 15, 2024 |
| FY2024 | Jul 2, 2022 | $11.76M | Oct 15, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 28, 2025 | ($8.32M) | Sep 17, 2025 |
| FY2024 | Jun 29, 2024 | ($1.99M) | Oct 15, 2024 |
| FY2024 | Mar 30, 2024 | ($2.22M) | Oct 15, 2024 |
| FY2024 | Dec 30, 2023 | $1.08M | Oct 15, 2024 |
| FY2024 | Sep 30, 2023 | $335.0K | Oct 15, 2024 |
| FY2024 | Jul 1, 2023 | $1.06M | Oct 15, 2024 |
| FY2024 | Apr 1, 2023 | $1.98M | Oct 15, 2024 |
| FY2024 | Dec 31, 2022 | $967.0K | Oct 15, 2024 |
| FY2024 | Oct 1, 2022 | $1.15M | Oct 15, 2024 |
| FY2024 | Jul 2, 2022 | $968.0K | Oct 15, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 28, 2025 | $562.0K | Sep 17, 2025 |
| FY2024 | Jun 29, 2024 | $117.0K | Oct 15, 2024 |
| FY2024 | Mar 30, 2024 | ($575.0K) | Oct 15, 2024 |
| FY2024 | Dec 30, 2023 | $3.95M | Oct 15, 2024 |
| FY2024 | Sep 30, 2023 | $3.27M | Oct 15, 2024 |
| FY2024 | Jul 1, 2023 | $4.22M | Oct 15, 2024 |
| FY2024 | Apr 1, 2023 | $5.13M | Oct 15, 2024 |
| FY2024 | Dec 31, 2022 | $3.61M | Oct 15, 2024 |
| FY2024 | Oct 1, 2022 | $3.36M | Oct 15, 2024 |
| FY2024 | Jul 2, 2022 | $2.26M | Oct 15, 2024 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 28, 2025 | $9.16M | Sep 17, 2025 |
| FY2024 | Jun 29, 2024 | $2.10M | Oct 15, 2024 |
| FY2024 | Mar 30, 2024 | $2.23M | Oct 15, 2024 |
| FY2024 | Dec 30, 2023 | $1.76M | Oct 15, 2024 |
| FY2024 | Sep 30, 2023 | $2.24M | Oct 15, 2024 |
| FY2024 | Jul 1, 2023 | $2.57M | Oct 15, 2024 |
| FY2024 | Apr 1, 2023 | $2.58M | Oct 15, 2024 |
| FY2024 | Dec 31, 2022 | $2.29M | Oct 15, 2024 |
| FY2024 | Oct 1, 2022 | $2.30M | Oct 15, 2024 |
| FY2024 | Jul 2, 2022 | $2.35M | Oct 15, 2024 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 28, 2025 | $26.70M | Sep 17, 2025 |
| FY2024 | Jun 29, 2024 | $6.96M | Oct 15, 2024 |
| FY2024 | Mar 30, 2024 | $6.42M | Oct 15, 2024 |
| FY2024 | Dec 30, 2023 | $6.06M | Oct 15, 2024 |
| FY2024 | Sep 30, 2023 | $5.78M | Oct 15, 2024 |
| FY2024 | Jul 1, 2023 | $7.36M | Oct 15, 2024 |
| FY2024 | Apr 1, 2023 | $6.96M | Oct 15, 2024 |
| FY2024 | Dec 31, 2022 | $5.74M | Oct 15, 2024 |
| FY2024 | Oct 1, 2022 | $5.66M | Oct 15, 2024 |
| FY2024 | Jul 2, 2022 | $7.15M | Oct 15, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 28, 2025 | $18.93M | Sep 17, 2025 |
| FY2025 | Jun 29, 2024 | $13.78M | Sep 17, 2025 |
| FY2024 | Jul 1, 2023 | ($11.31M) | Oct 15, 2024 |
| FY2024 | Jul 2, 2022 | ($4.91M) | Oct 15, 2024 |
| FY2022 | Jul 3, 2021 | ($15.05M) | Sep 14, 2022 |
| FY2022 | Jun 27, 2020 | ($31.00M) | Sep 14, 2022 |
| FY2021 | Jun 29, 2019 | $919.0K | Sep 16, 2021 |
| FY2020 | Jun 30, 2018 | $3.12M | Sep 11, 2020 |
| FY2019 | Jul 1, 2017 | $2.28M | Sep 12, 2019 |
| FY2018 | Jul 2, 2016 | $4.58M | Sep 10, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 28, 2025 | $4.10M | Sep 17, 2025 |
| FY2025 | Jun 29, 2024 | $3.96M | Sep 17, 2025 |
| FY2024 | Jul 1, 2023 | $9.77M | Oct 15, 2024 |
| FY2024 | Jul 2, 2022 | $6.81M | Oct 15, 2024 |
| FY2022 | Jul 3, 2021 | $10.60M | Sep 14, 2022 |
| FY2022 | Jun 27, 2020 | $8.62M | Sep 14, 2022 |
| FY2021 | Jun 29, 2019 | $8.39M | Sep 16, 2021 |
| FY2020 | Jun 30, 2018 | $4.52M | Sep 11, 2020 |
| FY2019 | Jul 1, 2017 | $9.31M | Sep 12, 2019 |
| FY2018 | Jul 2, 2016 | $13.28M | Sep 10, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 28, 2025 | $315.87M | Sep 17, 2025 |
| FY2025 | Jun 29, 2024 | $355.34M | Sep 17, 2025 |
| FY2024 | Mar 30, 2024 | $370.10M | Oct 15, 2024 |
| FY2024 | Dec 30, 2023 | $375.45M | Oct 15, 2024 |
| FY2024 | Sep 30, 2023 | $389.07M | Oct 15, 2024 |
| FY2024 | Jul 1, 2023 | $418.27M | Oct 15, 2024 |
| FY2024 | Jul 2, 2022 | $406.92M | Oct 15, 2024 |
| FY2022 | Jul 3, 2021 | $361.85M | Sep 14, 2022 |
| FY2021 | Jun 27, 2020 | $304.86M | Sep 16, 2021 |
| FY2020 | Mar 28, 2020 | $291.5K | Sep 11, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 28, 2025 | $198.74M | Sep 17, 2025 |
| FY2025 | Jun 29, 2024 | $231.35M | Sep 17, 2025 |
| FY2024 | Mar 30, 2024 | $243.30M | Oct 15, 2024 |
| FY2024 | Dec 30, 2023 | $246.29M | Oct 15, 2024 |
| FY2024 | Sep 30, 2023 | $261.28M | Oct 15, 2024 |
| FY2024 | Jul 1, 2023 | $287.66M | Oct 15, 2024 |
| FY2024 | Jul 2, 2022 | $282.05M | Oct 15, 2024 |
| FY2022 | Jul 3, 2021 | $238.14M | Sep 14, 2022 |
| FY2021 | Jun 27, 2020 | $189.30M | Sep 16, 2021 |
| FY2020 | Jun 29, 2019 | $123.85M | Sep 11, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 28, 2025 | $117.13M | Sep 17, 2025 |
| FY2025 | Jun 29, 2024 | $123.99M | Sep 17, 2025 |
| FY2024 | Mar 30, 2024 | $126.80M | Oct 15, 2024 |
| FY2024 | Dec 30, 2023 | $129.16M | Oct 15, 2024 |
| FY2024 | Sep 30, 2023 | $127.79M | Oct 15, 2024 |
| FY2025 | Jul 1, 2023 | $130.62M | Sep 17, 2025 |
| FY2024 | Jul 2, 2022 | $124.88M | Oct 15, 2024 |
| FY2024 | Jul 3, 2021 | $123.71M | Oct 15, 2024 |
| FY2022 | Jun 27, 2020 | $115.56M | Sep 14, 2022 |
| FY2022 | Jun 29, 2019 | $114.46M | Sep 14, 2022 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Jun 29, 2019 | $0 | Sep 12, 2019 |
| FY2019 | Jun 30, 2018 | $9.96M | Sep 12, 2019 |
| FY2018 | Jul 1, 2017 | $9.96M | Sep 10, 2018 |
| FY2017 | Jul 2, 2016 | $9.96M | Sep 11, 2017 |
| FY2016 | Jun 27, 2015 | $9.96M | Sep 9, 2016 |
| FY2016 | Jun 28, 2014 | $1.74M | Sep 9, 2016 |
| FY2014 | Jun 29, 2013 | $0 | Sep 5, 2014 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 28, 2025 | $68.60M | Sep 17, 2025 |
| FY2025 | Jun 29, 2024 | $76.92M | Sep 17, 2025 |
| FY2024 | Mar 30, 2024 | $78.91M | Oct 15, 2024 |
| FY2024 | Dec 30, 2023 | $81.13M | Oct 15, 2024 |
| FY2024 | Sep 30, 2023 | $80.04M | Oct 15, 2024 |
| FY2024 | Jul 1, 2023 | $82.99M | Oct 15, 2024 |
| FY2024 | Jul 2, 2022 | $77.83M | Oct 15, 2024 |
| FY2022 | Jul 3, 2021 | $74.45M | Sep 14, 2022 |
| FY2021 | Jun 27, 2020 | $70.11M | Sep 16, 2021 |
| FY2020 | Jun 29, 2019 | $65.35M | Sep 11, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 28, 2025 | $1.38M | Sep 17, 2025 |
| FY2025 | Jun 29, 2024 | $4.75M | Sep 17, 2025 |
| FY2024 | Mar 30, 2024 | $5.26M | Oct 15, 2024 |
| FY2024 | Dec 30, 2023 | $2.95M | Oct 15, 2024 |
| FY2024 | Sep 30, 2023 | $3.57M | Oct 15, 2024 |
| FY2024 | Jul 1, 2023 | $3.60M | Oct 15, 2024 |
| FY2024 | Jul 2, 2022 | $1.71M | Oct 15, 2024 |
| FY2022 | Jul 3, 2021 | $3.47M | Sep 14, 2022 |
| FY2022 | Jun 27, 2020 | $553.0K | Sep 14, 2022 |
| FY2022 | Jun 29, 2019 | $601.0K | Sep 14, 2022 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 28, 2025 | $105.15M | Sep 17, 2025 |
| FY2024 | Jun 29, 2024 | $119.51M | Oct 15, 2024 |
| FY2023 | Jul 1, 2023 | $124.67M | Sep 26, 2023 |
| FY2022 | Jul 2, 2022 | $102.48M | Sep 14, 2022 |
| FY2021 | Jul 3, 2021 | $100.41M | Sep 16, 2021 |
| FY2020 | Jun 27, 2020 | $70.94M | Sep 11, 2020 |
| FY2020 | Sep 5, 2019 | $5.00M | Sep 11, 2020 |
| FY2019 | Jun 29, 2019 | $36.29M | Sep 12, 2019 |
| FY2020 | Sep 29, 2018 | $35.00M | Sep 11, 2020 |
| FY2018 | Jun 30, 2018 | $35.00M | Sep 10, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 28, 2025 | 0 | Sep 17, 2025 |
| FY2024 | Jun 29, 2024 | 0 | Oct 15, 2024 |
| FY2024 | Mar 30, 2024 | 0 | Oct 15, 2024 |
| FY2024 | Dec 30, 2023 | 0 | Oct 15, 2024 |
| FY2024 | Sep 30, 2023 | 0 | Oct 15, 2024 |
| FY2024 | Jul 1, 2023 | 0 | Oct 15, 2024 |
| FY2024 | Apr 1, 2023 | 0 | Oct 15, 2024 |
| FY2024 | Dec 31, 2022 | 0 | Oct 15, 2024 |
| FY2024 | Oct 1, 2022 | 0 | Oct 15, 2024 |
| FY2024 | Jul 2, 2022 | 0 | Oct 15, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 28, 2025 | 0 | Sep 17, 2025 |
| FY2024 | Jun 29, 2024 | 0 | Oct 15, 2024 |
| FY2024 | Mar 30, 2024 | 0 | Oct 15, 2024 |
| FY2024 | Dec 30, 2023 | 0 | Oct 15, 2024 |
| FY2024 | Sep 30, 2023 | 0 | Oct 15, 2024 |
| FY2024 | Jul 1, 2023 | 0 | Oct 15, 2024 |
| FY2024 | Apr 1, 2023 | 0 | Oct 15, 2024 |
| FY2024 | Dec 31, 2022 | 0 | Oct 15, 2024 |
| FY2024 | Oct 1, 2022 | 0 | Oct 15, 2024 |
| FY2024 | Jul 2, 2022 | 0 | Oct 15, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 28, 2025 | 10.76M | Sep 17, 2025 |
| FY2025 | Jun 29, 2024 | 10.76M | Sep 17, 2025 |
| FY2024 | Mar 30, 2024 | 10.76M | Oct 15, 2024 |
| FY2024 | Dec 30, 2023 | 10.76M | Oct 15, 2024 |
| FY2024 | Sep 30, 2023 | 10.76M | Oct 15, 2024 |
| FY2024 | Jul 1, 2023 | 10.76M | Oct 15, 2024 |
| FY2024 | Jul 2, 2022 | 10.76M | Oct 15, 2024 |
| FY2022 | Jul 3, 2021 | 10.76M | Sep 14, 2022 |
| FY2021 | Jun 27, 2020 | 10.76M | Sep 16, 2021 |
| FY2020 | Jun 29, 2019 | 10.76M | Sep 11, 2020 |